DK2403
DK2403 (compound 25) is a MAP2K7 inhibitor (IC50= 0.01 μM) . DK2403 can effectively inhibit MAP2K7 without significantly disrupting the larger kinase group and can be used to study childhood T-cell acute lymphoblastic leukemia[1].
Product Specifications
CAS Number
[2902651-64-1]
UNSPSC
12352005
Target
P38 MAPK
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Purity
98.24
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(CCl)NC1=CC(OC2=NC=NC(NCC3=CC=CC=C3)=C2)=CC=C1
Molecular Formula
C19H17ClN4O2
Molecular Weight
368.82
References & Citations
[1]Kim DR, et al. Rational Design of Highly Potent and Selective Covalent MAP2K7 Inhibitors. ACS Med Chem Lett. 2023 Apr 17;14 (5) :606-613.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1456755-05 0.02 mg (Baculovirus)
Recombinant Neurospora crassa ATPase get3 (get3)
Ask
View Details MBS1456755-06 0.02 mg (Mammalian-Cell)
Recombinant Neurospora crassa ATPase get3 (get3)
Ask
View Details